Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 16.35
(-25.78%)
USD 16.35
(-25.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 691 Million NZD | -2.01% |
| 2023 | 705.2 Million NZD | 9.66% |
| 2022 | 643.1 Million NZD | 4.01% |
| 2021 | 618.3 Million NZD | 19.48% |
| 2020 | 517.5 Million NZD | 10.13% |
| 2019 | 469.9 Million AUD | 9.23% |
| 2018 | 430.2 Million AUD | 9.08% |
| 2017 | 394.37 Million AUD | 12.43% |
| 2016 | 350.77 Million AUD | 26.38% |
| 2015 | 277.54 Million AUD | 8.63% |
| 2014 | 255.49 Million AUD | 14.1% |
| 2013 | 223.91 Million AUD | 8.08% |
| 2012 | 207.18 Million AUD | 1.94% |
| 2011 | 203.23 Million AUD | 6.82% |
| 2010 | 190.26 Million AUD | 15.63% |
| 2009 | 164.54 Million AUD | 19.06% |
| 2008 | 138.2 Million AUD | 5.48% |
| 2007 | 131.02 Million AUD | 20.68% |
| 2006 | 108.56 Million AUD | 17.47% |
| 2005 | 92.42 Million AUD | 13.21% |
| 2004 | 81.64 Million AUD | 8.25% |
| 2003 | 75.41 Million AUD | 1145.71% |
| 2002 | 6.05 Million AUD | -90.43% |
| 2001 | 63.26 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 178.75 Million NZD | -21.53% |
| 2024 Q2 | 333.5 Million NZD | 97.22% |
| 2024 Q3 | 227.79 Million NZD | -31.69% |
| 2024 FY | 691 Million NZD | -2.01% |
| 2024 Q1 | 169.1 Million NZD | -47.11% |
| 2023 Q1 | 149.6 Million NZD | -46.91% |
| 2023 Q2 | 286.5 Million NZD | 91.51% |
| 2023 Q4 | 319.7 Million NZD | 108.21% |
| 2023 FY | 705.2 Million NZD | 9.66% |
| 2023 Q3 | 153.55 Million NZD | -46.4% |
| 2022 Q4 | 281.8 Million NZD | 100.71% |
| 2022 Q1 | 132.7 Million NZD | -52.71% |
| 2022 FY | 643.1 Million NZD | 4.01% |
| 2022 Q2 | 265.3 Million NZD | 99.92% |
| 2022 Q3 | 140.4 Million NZD | -47.08% |
| 2021 Q1 | 123.69 Million NZD | -48.37% |
| 2021 Q3 | 138.25 Million NZD | -45.29% |
| 2021 Q4 | 280.6 Million NZD | 102.97% |
| 2021 FY | 618.3 Million NZD | 19.48% |
| 2021 Q2 | 252.7 Million NZD | 104.28% |
| 2020 Q1 | 111.3 Million NZD | 1.46% |
| 2020 Q4 | 239.6 Million NZD | 98.84% |
| 2020 Q3 | 120.49 Million NZD | -44.44% |
| 2020 FY | 517.5 Million NZD | 10.13% |
| 2020 Q2 | 216.9 Million NZD | 94.88% |
| 2019 FY | 469.9 Million AUD | 9.23% |
| 2019 Q4 | 109.69 Million NZD | 0.0% |
| 2019 Q3 | 109.69 Million NZD | 6.5% |
| 2019 Q2 | 103 Million NZD | 0.0% |
| 2019 Q1 | 103 Million NZD | 6.74% |
| 2018 Q3 | 96.5 Million NZD | 2.93% |
| 2018 FY | 430.2 Million AUD | 9.08% |
| 2018 Q1 | 93.75 Million NZD | 0.7% |
| 2018 Q2 | 93.75 Million NZD | 0.0% |
| 2018 Q4 | 96.5 Million NZD | 0.0% |
| 2017 Q1 | 81.29 Million NZD | 0.93% |
| 2017 FY | 394.37 Million AUD | 12.43% |
| 2017 Q4 | 93.1 Million NZD | 0.0% |
| 2017 Q3 | 93.1 Million NZD | 14.51% |
| 2017 Q2 | 81.29 Million NZD | 0.0% |
| 2016 Q4 | 80.55 Million NZD | 0.0% |
| 2016 Q3 | 80.55 Million NZD | 5.0% |
| 2016 Q2 | 76.71 Million NZD | 0.0% |
| 2016 Q1 | 76.71 Million NZD | 27.01% |
| 2016 FY | 350.77 Million AUD | 26.38% |
| 2015 Q1 | 61.11 Million NZD | 11.3% |
| 2015 Q3 | 60.4 Million NZD | -1.16% |
| 2015 Q4 | 60.4 Million NZD | 0.0% |
| 2015 FY | 277.54 Million AUD | 8.63% |
| 2015 Q2 | 61.11 Million NZD | 0.0% |
| 2014 Q1 | 55.59 Million NZD | 14.05% |
| 2014 FY | 255.49 Million AUD | 14.1% |
| 2014 Q3 | 54.9 Million NZD | -1.24% |
| 2014 Q2 | 55.59 Million NZD | 0.0% |
| 2014 Q4 | 54.9 Million NZD | 0.0% |
| 2013 Q4 | 48.74 Million NZD | 0.0% |
| 2013 Q3 | 48.74 Million NZD | 0.0% |
| 2013 FY | 223.91 Million AUD | 8.08% |
| 2012 FY | 207.18 Million AUD | 1.94% |
| 2011 FY | 203.23 Million AUD | 6.82% |
| 2010 FY | 190.26 Million AUD | 15.63% |
| 2009 FY | 164.54 Million AUD | 19.06% |
| 2008 FY | 138.2 Million AUD | 5.48% |
| 2007 FY | 131.02 Million AUD | 20.68% |
| 2006 FY | 108.56 Million AUD | 17.47% |
| 2005 FY | 92.42 Million AUD | 13.21% |
| 2004 FY | 81.64 Million AUD | 8.25% |
| 2003 FY | 75.41 Million AUD | 1145.71% |
| 2002 FY | 6.05 Million AUD | -90.43% |
| 2001 FY | 63.26 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -24032.766% |
| Ansell Limited | 495.5 Million USD | -39.455% |
| Ansell Limited | 495.5 Million USD | -39.455% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -734.503% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -39824.75% |
| Psykey, Inc. | 1.21 Million USD | -56843.666% |
| ConvaTec Group Plc | 910.31 Million USD | 24.092% |
| ConvaTec Group Plc | 872.5 Million USD | 20.802% |
| Encision Inc. | 3.77 Million USD | -18196.178% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -487168.266% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -628476.107% |
| Innovative MedTech Inc. | 6.09 Million USD | -11229.724% |
| LifePoint, Inc. | 7.42 Million USD | -9207.814% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -10783.604% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -80718.713% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -95061.499% |
| Reflect Scientific, Inc. | 1.06 Million USD | -64861.986% |
| SmileDirectClub, Inc. | 517 Million USD | -33.655% |
| Sector 10, Inc. | 39.84 Thousand USD | -1734163.628% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 89.598% |
| SheerVision, Inc. | 2.33 Million USD | -29535.856% |
| United Health Products, Inc. | 2.42 Million USD | -28376.773% |
| Vasamed, Inc. | 4.67 Million USD | -14687.347% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -26873.18% |
| Yubo International Biotech Limited | 1.25 Million USD | -54833.916% |